The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: Are there barriers to ideal care?
 
Isabelle Phuong Le
No Relationships to Disclose
 
Anand B. Karnad
No Relationships to Disclose
 
Christos Fountzilas
No Relationships to Disclose
 
Yuanyuan Liang
No Relationships to Disclose
 
Alex V. Mejia
No Relationships to Disclose
 
Marcela Mazo- Canola
No Relationships to Disclose
 
Selena Juarez Stuart
No Relationships to Disclose
 
Elizabeth Ann Bowhay-Carnes
No Relationships to Disclose
 
Jay C Shiao
No Relationships to Disclose
 
Roy Liu
No Relationships to Disclose
 
Praveena Iruku
No Relationships to Disclose
 
Tamna Wangjam
No Relationships to Disclose
 
Steven D. Weitman
Leadership - Tolero Pharmaceuticals
Stock and Other Ownership Interests - Azaya Therapeutics; miRNA Therapeutics; Tolero Pharmaceuticals
Consulting or Advisory Role - Amgen; Azaya Therapeutics; Millennium; miRNA Therapeutics; Sanofi; Sunesis Pharmaceuticals; Tolero Pharmaceuticals
Travel, Accommodations, Expenses - Acetylon Pharmaceuticals; Sunesis Pharmaceuticals; Tolero Pharmaceuticals